|Publication number||US3812854 A|
|Publication date||May 28, 1974|
|Filing date||Oct 20, 1972|
|Priority date||Oct 20, 1972|
|Publication number||US 3812854 A, US 3812854A, US-A-3812854, US3812854 A, US3812854A|
|Inventors||R Buckles, M Keller, A Michaels|
|Original Assignee||R Buckles, M Keller, A Michaels|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (8), Referenced by (324), Classifications (12)|
|External Links: USPTO, USPTO Assignment, Espacenet|
ilnited States Patent Michaels et a1.
[ May 28, 1974 Primary Examiner-Richard A. Gaudet Assistant Examiner-Lee S. Cohen Attorney, Agent, or Firm-Thomas E. Ciotti; Edward L. Mandell; Paul L. Sabatine  ABSTRACT A device for the ultrasonic nebulization of liquids. Nebulization takes place in a porous solid body the porosity of which determines the size of the liquid particles generated. The device is especially suitable for nebulizing liquid medicaments for inhalation therapy.
8 Claims, 3 Drawing Figures 1 1 ULTRASONIC NEBULIZER  lnventors: Alan S. Michaels, 97 Mt. Vernon,
Atherton; Richard G. Buckles, 491
Middle Ct., Menlo Park, both of Calif. 94025; Michael P. Keller, 2272 Latham St., Mountain View, Calif. 94040  Filed: Oct. 20, 1972  App]. No.: 299,194
 US. Cl 128/194, 128/D1G. 2, 239/102  Int. Cl A6lm 15/00  Field of Search 128/194, DIG. 2, 172, 173, 128/193, 145.8, 145.6; 259/D1G. 44; 239/102, 4, 338
 References Cited UNITED STATES PATENTS 2,658,169 11/1953 Barret 128/172 x 2 1&4
18 HIGH FREQUENCY G EN ERATOR RNTENIENNN RM I $812,854
/l4 [2 HIGH x FREQUENCY GENERATOR x LIQUID I N; IG.I F SUPPLY I? I LIQUID MOMMA l GENERATOR 16 I8 Y SUPPLY 1 ULTRASONM NEBULIZER BACKGROUND OF THE INVENTION 1. Field Of The Invention This invention relates to ultrasonic nebulizers. More particularly, it relates to a device for ultrasonically producing liquid aerosols having controlled particle size. In a preferred embodiment, the invention relates to an improved ultrasonic nebulizer for inhalation therapy.
2. The Prior Art The art is replete with processes which employ aerosols of liquids. Paints, biocides, personal and home care products, gas chromatography and spectroscopy samples, and inhalable drugs are representative of the many materials which are advantageously employed as aerosols. Most commonly, aerosols are generated by drawing the liquid into a high velocity stream of propellant gas. With the growing awareness of the health hazards posed by many of the known propellants, especially the Freon-type gases, other methods of generating aerosols are receiving increased attention.
It is known that aerosols can be generated ultrasonically. A common form of ultrasonic nebulizer achieves atomization by the disintegration of the geyser which is produced in a body of liquid by contacting the liquid with a focused beam of ultrasonic compressed wave energy. Devices of this type have been used, for example, in inhalation therapy (see U.S. Pat. No. 3,561,444 issued Feb. 9, l97l to Boucher or No. 3,387,607 issued June 1 1, 1968 to Gauthier et al.) and in sample atomization (see U.S. Pat. No. 3,325,976 issued June 20, 1967 to West). Another known type of ultrasonic nebulizer achieves atomization by dripping the liquid to be dispersed onto a continuously ultrasonically vibrating solid plate which breaks the liquid into a variety of particles. Such a device is shown in U.S. Pat. No. 3,291,122 issued Dec. 13, 1966 to Engstrom et al.
known that the point at which an aerosol particle deposits in the respiratory system is a function of particle size; micron particles are laid down in the mouth and larynx, 6 to 9 micron particles are preferentially.
deposited in the bronchi, 3 to 6 micron particles are preferentially deposited in the bronchioli, 1 to 3 micron particles are deposited in the alveoli, while particles much smaller than about 1-micron are not retained in the respiratory system by Brownian collision with all walls; most of these particles are exhaled.
Many respiratory diseases affect only one-of the areas of the respiratory system: for example, pneumonia and emphysema affect the alveoli, bronchitis affects the bronchioli, asthma affects the bronchi or bronchioli, etc. Since the drugs used to treat these diseases, for example, epinephrine, norepinephrine, prostaglandins, steroids, antibiotics, detergents and the like are often highly potent and/or systemically toxic, it would be of utmost advantage to minimize drug dosage by delivering the drug precisely to the affected area. More precise particle size control than possible heretofore would help minimize extraneous drug applications.
Another way to reduce drug dosage during inhalation therapy would be to deliver the drug as a precisely timed pulse. It has been found that the flow of gas in and out of the respiratory system has essentially plug flow characteristics with the first gas inspired eventually filling the most distant alveoli, the last gas inspired filling only the larynx, etc. Precise delivery of an accurately determined pulse of atomized drug at an accurately determined point during inspiration, thus would result in further control of the location of drug deposit.
Prior ultrasonic nebulizers are not suitable for accurate Both of these conventional types of nebulizing devices can effectively continuously produce large volumes of crude aerosol but both have three serious disadvantages when preceise nebulization is desired. First, they do not permit accurate control of the amount of liquid atomized; second, they also require relatively long times (often I to 10 seconds) after starting to generate a stable consistent aerosol, and finally, they fail to directly generate an aerosol having uniformly sized particles (so-called monodispersed aerosols).
This last failing is especially serious since it is often necessary or desirable to have a monodispersed aerosol. On a theoretical basis, it has been shown that continuous ultrasonic nebulizers should produce uniform particles related in diameter to the reciprocal of the ultrasonic frequency employed. In practice, however, prior ultrasonic atomizers have produced a variety of extraneous large particles which must be screened, settled or otherwise removed, albeit incompletely, as may be noted in U.S. Pat. No. 3,291,122 and Boucher et al. 26 Annals ofAllergy 591 at FIG. 4 (1968). This inability to control particle size has limited the usefulness of conventional ultrasonic nebulizers especially in inhalation treatment of the respiratory system where precise control of particle size is most advantageous and true monodispersed aerosols have been long desired.
The respiratory system comprises a series of decreasing diameter branched tubes, including the mouth, larynx, trachea, bronchi, bronchioli and alveoli. It is pulsed delivery. These devices often require at least several seconds of tuning to achieve a usable aerosol. When used in pulsed applications, conventional ultrasonic nebulizers rely upon interrupting the transmission of the aerosol by bulky ducts and poorly controllable valves rather than by controlling the aerosols generation.
OBJECTS OF THE INVENTION Accordingly, it is an object of the present invention to provide a new and improved nebulizer of the ultrasonic type.
A further object of this invention is to provide an ultrasonic nebulizer which will permit precise control of the amount of liquid nebulized.
A further object of this invention is to provide an ultrasonic nebulizer which will permit control of the size of liquid particles formed.
Another object of this invention is to provide a device for the production of aerosols which may be used with improved efficiency for inhalation therapy or other therapeutic purposes.
Yet another object of this invention is to provide an ultrasonic nebulizer for inhalation therapy which can be controlled to deliver a medicament-containing aerosol in the form of a pulse of particular particle size and amount of medicament; positioned at a particular point in the inspiration cycle.
STATEMENT OF THE INVENTION It has now been found that the foregoing objects, as well as other objects, advantages, and features which will become apparent from the detailed description to follow, are attained by a nebulizer which includes a porous body having a defined intercommunicating pore structure, an oscillator capable of vibrating the porous body at an ultrasonic frequency and a system for supplying liquid to be nebulized to the pores of the porous body.
BRIEF DESCRIPTION OF THE DRAWINGS In the drawings,,..wherein like reference numerals designate like parts:
FIG. 1 is an essentially diagrammatic cross-sectional view of an embodiment of the ultrasonic nebulizer of the invention;
FIG. 2 is an essentially diagrammatic cross-sectional view of another configuration of a nebulizer of the invention, and
FIG. 3 is a cross-sectional view of yet another configuration of the nebulizer of the invention.
DETAILED DESCRIPTION OF THE INVENTION As illustrated in FIG. 1, an ultrasonic nebulizer l embodying the present invention has a porous solid body 11 having a defined fixed intercommunicating pore structure. Solid body 11 is affixed to ultrasonic horn or antennuator 12 which is in turn attached to a suitable piezoelectric crystal or other electro-mechanical transducer 14. Crystal 14 is connected via cable 16 to high frequency signal generator which produces an ultrasonic signal of adequate power to oscillate crystal 14. The frequency generated by generator 15 is very suitably the resonant frequency of crystal 14 or a harmonic thereof. Cable 16, generator 15, crystal l4 and horn 12 in combination cause porous body 11 to vibrate at an ultrasonic frequency. Liquid to be nebulized is forced under pressure from liquid supply 17 through conduit 18 through concentric channel (or bore) 19 in horn 12 to the interconnected pores of porous body 11 which communicate with channel 19. Conduit 18 is attached to horn 12 in a manner which does not interfere with the ultrasonic oscillation of horn l2 and porous body 11. As will be appreciated by those skilled in the art, the embodiment of the invention illustrated in FIG. 1 is much simplified to clearly set out the invention. Details, such as for example a housing for the nebulizer or the method of flexibly attaching crystal 14 to the hous ing or the exact method of fastening conduit 18 to channel 19, may be supplied by one skilled in the art without departing from the spirit of this invention. Likewise, minor modifications, such as the addition of a capability for cooling crystal 14, may be employed.
In operation, liquid to be nebulized is passed through conduit 18 and channel 19 to porous body 11. The pores of body 11 are intercommunicating, so that liquid can be conducted through solid body 11. Thus the liquid from channel 19 moves to the outer surface of porous body 11 and there is nebulized by the ultrasonic vibration into an aerosol having a particle size distribution which is related to the diameters of the pores of body 11.
In accordance with the present invention, liquids are nebulized to aerosols using an ultrasonically vibrating porous body having a fixed pore structure. Unlike prior ultrasonic nebulizers wherein the size of the particles in the aerosol was determined by the frequency of the ultrasonic vibration, the particle sizes achieved with the instant nebulizers are related to the internal geometry of this porous body. Aerosol particle size is a function Particle diameter 2 X pore diameter For example, when a porous body having uniform 10 micron pores is used in the present invention, the aerosol particles which result are uniformly from about 18 to 22 microns in diameter. When a porous body having uniform 4 mircon diameter external surface pores is substituted an aerosol having particles from about 7 to 9 micron in diameter is formed. This particle size to pore diameter relationship appears to hold over the range of body external pore diameters of from about 0.5 micron to about 50 microns.
When a body having pores of a variety of sizes is employed, a multi-sized aerosol is obtained. In the preferred embodiments of this invention, wherein aerosols for inhalation therapy are produced, it is most often preferred to have uniform particle sizes. Bodies having uniform pore diameters in the range of from 0.5 to 5 microns produce aerosols ideal for many inhalation applications. Most specifically, bodies having all or a major proportion of their pores in the range of from 0.5 to 1.5 microns produce aerosols excellentfor inhalation treatment of the alveoli, bodies having their pores in the range of from 1.5 to 3 microns produce aerosols well suited for treating the bronchioli, while 3 to 5 micron pore bodies produce aerosols most useful for treating the bronchi. As used herein, a body is defined to have a uniform pore diameter within a range when at least about percent of all its pores fall within the given range. Preferably at least about percent of all the pores fit within the specified range.
The pores of the porous body must be joined into an intercommunicating network since when used in accord with this invention, liquid will be passed from one side of the porous body through to the other side.
To achieve reproducible results, the size of the outer pores of the porous body should be fixed. The material of construction of the porous body is not critical so long as it provides a fixed pore size. Porous ceramic oxides may be used as well as porous glasses and metal frits, compressed porous plastics, and certain filters (e.g., nucleopore). These materials are readily available, being used conventionally as filters and catalyst supports.
The porous body should be relatively thin, generally not more than about 1 or 2 cms thick, preferably from 0.01 to 1 cm thick. Undesirably large amounts of energy are required to force the liquid to be nebulized through thicker bodies.
The porous body may be comprised of several layers, for example an internal macroporous layer, which permits the facile passage of liquid, in combination with an outer layer or skin having the required pore size distribution. Such a material can be made by carefully annealing or firing the surface of a macroporous support or by bonding a thin sheet of microporous ceramic, for example 0.005 cm thick, to a sheet of macroporous ceramic, for example 1 cm thick.
The porous body must be vibrated ultrasonically to produce the desired aerosol. This may be carried out by connecting the body to an ultrasonic vibrator such as, for example, by affixing the body to a piezoelectric ceramic crystal. This connection is preferably made through an antennuator horn, which when correctly matched to the piezoelectric crystal frequency, effeciently transmits the ultrasonic oscillation of the piezoelectric crystal to the porous body and if sized correctly permits the ultrasonic energy to be multiplied and focused in the porous body where nebulization occurs. The size and shape of the antennuator horn 12 is not critical. Ideally, it is sized taking into consideration its material and the velocity of ultrasonic waves therethrough to achieve a harmonic relationship at the frequency employed.
The porous body is attached or affixed to the antennuator horn by a method enabling a tight fit and firm attachment to be achieved. The exact method of affixing the porous body to the antennuator horn, while not critical, must be chosen with care. A tight fit must be achieved. Glueing or soldering can be used so long as the pores of the porous body are not blocked or appreciably obstructed. Clamping or threading the porous body to the antennuator horn are acceptable means of attachment.
The antennuator horn is attached to a piezoelectric ceramic crystal or transducer 14. Piezoelectric crystals and their use as transducers are well known. They may be made of materials such as lead zirconate or titanate, and calcium zironate or titanate, with or without traces of salts, for example yttrium, lanthanum, strontium or cobalt. To permit good electrical contact, they generally are coated on two opposite faces with electrically conducting metallic layers. A high frequency signal generator drives the piezoelectric crystal. This generator is capable of producing a signal having a frequency of from l5.00 kilohertz (Khz) to about 100.00 Khz. The power output required depends upon the amount of liquid being nebulized per unit time and the area and porosity of the porous body. As a general rule, at least 20,000 dyne-cm are needed to nebulize 1 cc of liquid into less than 20 micron particles. Best results are obtained when the power output is from about 1 X to about 1 X 10 dyne-cm.
Liquid to be nebulized is supplied to the porous body through channel 19 in antennuator horn 12. Channel 19 is illustrated as coaxial with horn 12. This is not critical. It is essential that channel 19 contact body 11 in a manner that the pores of body lll can communicate with channel 19 and that liquid passing through channel 19 can pass through the pores to the surface of body 11 and there be nebulized. Liquid is fed to channel 19 under pressure via conduit 17 from liquid supply 16. It is required that the liquid be fed under pressure if a substantial feed rate is to be achieved. The pressure employed will depend on the pore size of body 11, the viscosity of the liquid being fed, etc. Generally, pressure of from I to 20 psi are suitable and may be achieved by for example, moving the liquid with pumps, compressed gas cylinders and the like.
A great variety of liquids may be nebulized by an apparatus as illustrated in FIG. 1. Water and aqueous solutions, such as of drugs, herbicides, dilute paints and dyes and the like are suitable, as are non-aqueous liquids and solutions having viscosities not appreciably greater than about 500 centipoises. Viscous liquids, such as heavy oils, generally are not suitable for nebulization with the present apparatus as they tend to clog the porous body. Light organic materials such as lower hydrocarbons, oxyhydrocarbons and liquid halohydrocarbons may be easily nebulized for a variety of uses such as for flame spectrographic analysis and similar scientific investigations. Liquid medicaments, both neat and in aqueous and non-aqueous solutions which meet the above viscosity criteria are very suitably nebulized by the device of this invention.
Medicaments which may be administered to the respiratory tract by the present invention include conventional inhalation therapy substances such as bronchodilator decongestants, for example, epinephrine, isoproterenol, isoetharime and phenylephrine; moistening thinning and detergent solutions such as superinone; mucolytic agents such as acetylcystune and enzymes, for example pancreatic enzyme; and water or saline humidity.
Turning now to FIG. 2, a diagrammatic illustration is given of an embodiment of the nebulizer of this invention adapted for use as an inhaler for inhalation therapy. The principle components of this inhaler inhaler 2) are the same as those of the nebulizer of FIG. 1, including porous body 11, antennuator horn l2, piezoelectric crystal 14, signal generator 15, cable 16 and liquid supply system 17, here shown as a pressure canister; connected to channel 19 via conduit 18. Inhaler 2 also has, in combination with the foregoing components, a mouthpiece 20 adapted at one end to fit the patients mouth and to admit air as well as medicament through its other end as illustrated, as well as means for automatically controlling the nebulizer during the respiration cycle. This automatic control includes an inspiration responsive detector 21, positioned in the airstream of mouthpiece 20, which reacts to changes in the velocity or pressure of the airstream within mouthpiece 20 thus signalling the commencement of inspiration to control 24 via means 22. Control 24 then opens valve 25 via line 26 and admits the desired amount of medicament from supply pressure canister 17, to line 18, channel 19 and porous body 11. Control 24 also turns on, via line 27, high frequency generator 15 which activates piezoelectric crystal 14 which ultrasonically vibrates horn 12 and attached porous body 11 to nebulize precisely the amount of medicament desired. Inhalation detector 21 and controller 24 may be set to deliver medicament throughout the inspiration cycle or in an especially advantageous mode of operation may be set to order a short burst (say from 0.1 to 1 second) of medication ata preset point during inspiration. This point may be based on the length of time from the start of inspiration or more preferably may be based on the volume of gas inspired. The volume may be simply derived by detecting and integrating the inspiration velocity. The nebulizer of this invention can produce a stable cosistant aerosol of uniform particle size essentially instantaneously, for example, within about 2 milliseconds. Thus it is possible to precisely-insert a burst of aerosolized medicament at any desired point in the inspiration cycle and therefore achieve much improved control of inhalation medicament delivery.
Although these constructional details are not illustrated, the inhaler of FIG. 2 can be constructed suitable for stationary or portable use. Because of the excellent direct control of particle size and amount of medicament nebulized, possible with the present invention, bulky filters, classifiers and the like are not required. Also, the electrical power demands of the inhaler of FIG. 2 are modest. Thus it can be constructed, if desired, to be battery operated in a highly portable form.
Turning now to FIG. 3, an embodiment of the invention, atomizer 3, suitable for generating bulk inhalation aerosols or for nebulizing liquid chemical samples for spectrographic or chromatographic analysis is shown. Atomizer 3 is similar to the embodiments of FIGS. 1 and 2 and includes porous body 11, which is here illustrated, not to scale, as a two layer body having a thin (0.05 cm) outer layer having the pore geometry which will give the particle size distribution desired the thicker (0.5 cm) inner layer having a macroporous structure adapted for the facile passage of liquid to be nebulized. Porous body 11 is attached to antennuator horn 12 by means of threaded compression collar 29. Horn 12 is attached to piezoelectric crystal 14 which is driven by ultrasonic oscillations generated by high frequency generator 15 and transmitted via cable 16. Liquid to be nebulized, for example water, is supplied under pressure by liquid supply 17 and line 18 to channel 19 on horn 12. Channel 19 is branched at its upper end where it contacts body 11. This facilitates the more ready passage and even distribution of liquid into body 11. The atomizer is mounted in housing 30, which is essentially sealed except for carrier gas inlet 31 and outlet 32. In operation, carrier gas, which for inhalation uses is usually air or oxygen containing a blend of gasses and for sample atomization is usually a noninterfering gas such as helium or nitrogen, is passed into housing 30 in inlet 31. A mixture of nebulized liquid and carrier gas is then withdrawn via outlet 32 and used as intended by means not shown.
- The following examples are merely illustrative of the present invention and are not to be considered as limiting the scope of the invention in any way.
EXAMPLE I An ultrasonic nebulizer, substantially as shown in FIG. I, is constructed. As porous body 11 is employed a 0.1 cm thick, 0.5 cm diameter disc of porous ceramic (aluminum oxide), having a relatively uniform porosity (some pores are as large as l or 12 microns, some are as small as about 4 microns) and a mean pore diameter of 6 microns. This body is glued on horn 12, care being taken to avoid blocking the pores of body 11. Antennuato'r horn 12 is constructed from brass and has the following dimensions: length, 3.12 inches, large diameter 0.45 inches, small diameter 0.20 inches. Channel 19 is coaxially bored in horn l2 and it has a diameter of 0.025 inches. A 0.50 inch piezoelectric ceramic is used as crystal [4. A Hewlett-Packard signal generator and McIntosh 2 l 00 Amplifier having a power output of 205 watts is employed as generator 15. Channel 19 is connected to a Harvard infusion pump. In operation, a 30.00 kilohertz oscillation of l8.2 watts power is applied to antennuator horn l2 and porous body 11. Water is pumped to porous body 11 at 20 psi pressure. The water nebulizes and is emitted from body 1 1 as an aerosol having particle diameters of from about 8 to about 20 microns corresponding to two times the diameter of the pores of body 11.
EXAMPLE 2 The experiment of Example I is repeated with one modification. As porous body 11 is employed a similarly sized disc of porous ceramic having a mean pore diameter of microns. The aerosol produced in this experiment has an average particle size of about microns.
EXAMPLE 3 The experiment of Example 1 is repeated with one modification. The antennuator horn having an internal bore and a porous ceramic tip is replaced with a solid horn having no ceramic tip. Liquid is fed to the end of the horn via an external 0.040 inch diameter'tube and a Harvard Positive Displacement pump, operated at 10 psi. An ultrasonic frequency varying from 25 KHz to KHz is applied, with energies of from X 10 400 X 10" dyne-cm. Throughout these ranges of frequencies and energies only randomly sized l0 70 micron particles of liquid are formed.
EXAMPLE 4 A series of experiments in accord with the experiment of Example 1 are conducted. In three experiments the liquid flow rate is varied from 0.0817 [Ll/SEC to 0.4l7 (Ll/Sec. The power requirement changes from 29 watts to 18 watts as the liquid feed is decreased. (all at 30 KHz). The particle size of the resulting aerosol remains constant averaging 15 microns.
In three additional experiments the glued porous body is replaced by a body of the same material attached by a threaded brass collar. Because of the resulting change in horn mass a new frequency (28 KHz) is found to be optimum. The aerosol particle sizes are the same as in the first three experiments. The power requirements at similar flow rates are reduced to form 18 to ll watts.
EXAMPLE 5 a. An inhaler substantially in accord with FIG. 2 is constructed. As liquid is employed a solution of medicament comprising epinephrine in distilled water. Controller 24 is set to order nebulization of medicament throughout the inspiration cycle. As porous body 11 is employed a glass frit having a uniform pore diameter of 5 to 6 microns. A patient inhales through mouthpiece 20. This flow of air is noted by detector 2]. Controller 24, responding to the signal of detector 21, then opens valve 25 and energizes high frequency generator 15 which in turn actuates crystal 14 which vibrates horn 12 and porous body 11. The medicament is nebulized into an aerosol having 10 to l2 micron particles which is inspired by the subject. These particles preferentially deposit on the throat and larynx of a patient employing the inhaler.
b. The experiment of part (a) is repeated using a 3 to 5 micron pore size glass frit. An aerosol having 6 to 10 micron particles is formed. This aerosol deposits preferentially in an inhaling patients bronchi.
c. Similarly, when a l to 2 micron frit is used, a 2 to 4 micron aerosol is formed, which deposits preferentially in a patients alveoli.
d. The experiment of part (c) is repeated with one change. Controller 24 is set to deliver only a short pulse of aerosol positioned at the initial portion of the inspiration cycle. In this case, the particles of medicament tiavell to and are primarily deposited in the most distant a V60 1.
EXAMPLE 6 A sample of lower ketones is to be analyzed by flame photometric detector gas chromatograph. An aerosolizer in accord with FIG. 3 is constructed using a bilayer ceramic porous body, the outer layer having an average 9 pore diameter of 2 microns, the inner having a 30 mircon average pore diameter. The mixed ketones are fed to the porous body, a suitable ultrasonic frequency is applied and a suitable carrier gas is fed via inlet 31. An aerosol of ketone is produced by the nebulizer and is carried therefrom by a carrier gas through the chromatograph to a flame photometeric detector where it is analyzed.
We claim as our invention:
1. An ultrasonic nebulizer for atomizing a liquid medicament comprising in combination:
A. a porous solid body having a defined intercommunicating pore structure adapted to receive said liquid medicament, pass said liquid medicament through its pores and discharge said liquid medicament through one of its ends, the diameters of at least 75 percent of the pore openings in said one end being in the range of from 0.5 to 5 microns;
B. means for supplying said liquid medicament to said porous body; and
C. means for vibrating said porous body comprising:
2. The nebulizer according to claim 1 wherein at least 85 percent of said diameters are in said range.
3. The nebulizer according to claim 1 wherein the sizes of said particles are essentially twice the diameters of said pore openings.
4. The nebulizer according to claim 1 wherein the porous body comprises an internal macroporous layer which permits facile passage of said liquid medicament and an outer porous layer whose exterior surface defines said one end.
5. The nebulizer according to claim 1, said nebulizer being adapted to atomize the liquid medicament for inhalation by a patient and including:
D. a mouthpiece for transferring the atomized liquid medicament from said one end of the porous body to the mouth of the patient, one end of which communicates with said one end of the porous body and the other end of which is adapted to be received within the mouth of the patient.
6. An ultrasonic nebulizer for atomizing a liquid according to claim 1 wherein the means for supplying liquid to the pores of the porous solid body comprises means for supplying liquid under pressure to a bore in the antennuator horn, which bore communicates with the pores of the porous solid body.
7. An ultrasonic nebulizer for atomizing a liquid medicament for inhalation by a patient comprising in combination, a cylindrical antennuator horn having a large diameter end and distal therefrom a small diameter end and a passageway extending from the small diameter end coaxially through the horn to an external opening; a porous solid body having external pores of diameter of from 0.5 microns to 5 microns affixed to the small diameter end of the antennuator horn, and having a defined intercommunicating pore structure in communication with the passageway; liquid supply means for supplying the liquid medicament to the external opening of the passageway; vibrating means for vibrating the cylindrical antennuator horn and afiixed porous solid body at a frequency of from about 15 Khz to about Khz; and a mouthpiece one end of which communicates with said external pores and the other end of which is adapted to be received within the mouth of the patient.
8. An ultrasonic nebulizer according to claim 7 including an inspiration responsive detector positioned within the airstream in said mouthpiece and operatively interconnected with said liquid supply means and said vibrating means, said detector being adapted to activate the liquid supply means and vibrating means in response to physical changes it detects within said air stream.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2658169 *||Mar 14, 1949||Nov 3, 1953||Centre Nat Rech Scient||Production of aerosols|
|US2949900 *||Jun 2, 1958||Aug 23, 1960||Albert G Bodine||Sonic liquid sprayer|
|US3121534 *||Sep 29, 1960||Feb 18, 1964||Exxon Research Engineering Co||Supersonic liquid atomizer and electronic oscillator therefor|
|US3214101 *||Mar 31, 1964||Oct 26, 1965||Little Inc A||Apparatus for atomizing a liquid|
|US3243122 *||Feb 24, 1965||Mar 29, 1966||Alvin A Snaper||Ultrasonic spray apparatus|
|US3400892 *||Dec 2, 1965||Sep 10, 1968||Battelle Development Corp||Resonant vibratory apparatus|
|US3561444 *||May 22, 1968||Feb 9, 1971||Bio Logics Inc||Ultrasonic drug nebulizer|
|US3653379 *||Aug 20, 1970||Apr 4, 1972||Glenn Joseph G||Adjustable pressure ippb ventilator|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3912168 *||Jan 30, 1975||Oct 14, 1975||Teledyne Ind Inc Teledyne Aqua||Irrigation lavage|
|US4106503 *||Mar 11, 1977||Aug 15, 1978||Richard R. Rosenthal||Metering system for stimulating bronchial spasm|
|US4109863 *||Aug 17, 1977||Aug 29, 1978||The United States Of America As Represented By The United States Department Of Energy||Apparatus for ultrasonic nebulization|
|US4119096 *||Aug 24, 1976||Oct 10, 1978||Siemens Aktiengesellschaft||Medical inhalation device for the treatment of diseases of the respiratory tract|
|US4261512 *||Feb 20, 1980||Apr 14, 1981||Boehringer Ingelheim Gmbh||Inhalation aerosol spray device|
|US4292973 *||Jan 3, 1980||Oct 6, 1981||Kabushiki Kaisha Kurio-Medikaru||Apparatus for refrigeration treatment|
|US4348873 *||Jun 23, 1981||Sep 14, 1982||Kabushiki Kaisha Kurio-Medikaru||Apparatus for refrigeration treatment|
|US4412538 *||Jul 31, 1981||Nov 1, 1983||Kabushiki Kaisha Kurio-Medikaru||Apparatus for refrigeration treatment|
|US4541966 *||Aug 24, 1984||Sep 17, 1985||Penlon Limited||Gas humidifying apparatus and method|
|US4546768 *||Dec 14, 1982||Oct 15, 1985||Feierabend Georg||Inhalation apparatus for animals|
|US4648393 *||Nov 2, 1984||Mar 10, 1987||Ackrad Laboratories, Inc.||Breath activated medication spray|
|US4776990 *||Sep 14, 1987||Oct 11, 1988||Rhinotherm Netzer Sereni||Method and apparatus for nebulizing a liquid|
|US4815661 *||Aug 3, 1987||Mar 28, 1989||Tomtec N.V.||Ultrasonic spraying device|
|US5063922 *||Oct 27, 1988||Nov 12, 1991||Etala-Hameen Keuhkovammayhdistys R.Y.||Ultrasonic atomizer|
|US5139016 *||Dec 29, 1989||Aug 18, 1992||Sorin Biomedica S.P.A.||Process and device for aerosol generation for pulmonary ventilation scintigraphy|
|US5152456 *||Dec 3, 1990||Oct 6, 1992||Bespak, Plc||Dispensing apparatus having a perforate outlet member and a vibrating device|
|US5221025 *||May 24, 1990||Jun 22, 1993||Conceptair Anstalt||Method and mechanical, electrical, or electronic apparatus for dispensing, issuing, or diffusing medicines, fragrances or other liquid or visous substances in the liquid phase or in the gaseous phase|
|US5259254 *||Sep 25, 1991||Nov 9, 1993||Cetac Technologies, Inc.||Sample introduction system for inductively coupled plasma and other gas-phase, or particle, detectors utilizing ultrasonic nebulization, and method of use|
|US5261601 *||Jul 6, 1992||Nov 16, 1993||Bespak Plc||Liquid dispensing apparatus having a vibrating perforate membrane|
|US5392648 *||Dec 17, 1991||Feb 28, 1995||Minnesota Mining And Manufacturing Company||Device for measuring a pre-determined volume of liquid flowing therethrough|
|US5407424 *||Feb 24, 1993||Apr 18, 1995||Scimed Life Systems, Inc.||Angioplasty perfusion pump|
|US5443059 *||Jan 14, 1994||Aug 22, 1995||Dragerwerk Ag||Ultrasonic atomizer with a metering unit|
|US5487378 *||Dec 17, 1991||Jan 30, 1996||Minnesota Mining And Manufacturing Company||Inhaler|
|US5497763 *||Dec 14, 1993||Mar 12, 1996||Aradigm Corporation||Disposable package for intrapulmonary delivery of aerosolized formulations|
|US5507277 *||Oct 28, 1994||Apr 16, 1996||Aradigm Corporation||Lockout device for controlled release of drug from patient-activateddispenser|
|US5509404 *||Jul 11, 1994||Apr 23, 1996||Aradigm Corporation||Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values|
|US5518179 *||Dec 4, 1992||May 21, 1996||The Technology Partnership Limited||Fluid droplets production apparatus and method|
|US5522385 *||Sep 27, 1994||Jun 4, 1996||Aradigm Corporation||Dynamic particle size control for aerosolized drug delivery|
|US5529055 *||May 27, 1994||Jun 25, 1996||L'oreal||Piezoelectric nebulizing apparatus|
|US5544646 *||May 20, 1994||Aug 13, 1996||Aradigm Corporation||Systems for the intrapulmonary delivery of aerosolized aqueous formulations|
|US5558085 *||Oct 28, 1994||Sep 24, 1996||Aradigm Corporation||Intrapulmonary delivery of peptide drugs|
|US5586550 *||Aug 31, 1995||Dec 24, 1996||Fluid Propulsion Technologies, Inc.||Apparatus and methods for the delivery of therapeutic liquids to the respiratory system|
|US5660166 *||Apr 10, 1996||Aug 26, 1997||Aradigm Corporation||Systems for the intrapulmonary delivery of aerosolized aqueous formulations|
|US5672581 *||Oct 28, 1994||Sep 30, 1997||Aradigm Corporation||Method of administration of insulin|
|US5694919 *||Oct 27, 1995||Dec 9, 1997||Aradigm Corporation||Lockout device for controlled release of drug from patient-activated dispenser|
|US5709202 *||May 21, 1993||Jan 20, 1998||Aradigm Corporation||Intrapulmonary delivery of aerosolized formulations|
|US5718222 *||May 30, 1995||Feb 17, 1998||Aradigm Corporation||Disposable package for use in aerosolized delivery of drugs|
|US5724957 *||Jul 28, 1995||Mar 10, 1998||Aradigm Corporation||Intrapulmonary delivery of narcotics|
|US5735263 *||Apr 15, 1996||Apr 7, 1998||Aradigm Corporation||Lockout device for controlled release of drug from patient-activated dispenser|
|US5743250 *||Nov 22, 1996||Apr 28, 1998||Aradigm Corporation||Insulin delivery enhanced by coached breathing|
|US5758637 *||Feb 21, 1996||Jun 2, 1998||Aerogen, Inc.||Liquid dispensing apparatus and methods|
|US5771882 *||Sep 9, 1996||Jun 30, 1998||Siemens Elema Ab||Anesthetic administration apparatus which delivers anesthetic in microdroplets|
|US5792057 *||Nov 26, 1997||Aug 11, 1998||Aradigm Corporation||Ventilation imaging using a fine particle aerosol generator|
|US5819726 *||Feb 4, 1997||Oct 13, 1998||Aradigm Corporation||Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease|
|US5823178 *||Aug 2, 1996||Oct 20, 1998||Aradigm Corporation||Disposable package for use in aerosolized delivery of drugs|
|US5826570 *||Apr 23, 1997||Oct 27, 1998||Aradigm Corporation||Delivery of aerosol medications for inspiration|
|US5829436 *||Jan 27, 1997||Nov 3, 1998||Aradigm Corporation||Ventilation imaging using a fine particle aerosol generator|
|US5873358 *||Apr 29, 1998||Feb 23, 1999||Aradigm Corporation||Method of maintaining a diabetic patient's blood glucose level in a desired range|
|US5884620 *||Apr 25, 1997||Mar 23, 1999||Aradigm Corporation||Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume|
|US5888477 *||Jan 31, 1997||Mar 30, 1999||Aradigm Corporation||Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin|
|US5910301 *||Mar 7, 1997||Jun 8, 1999||Aradigm Corporation||Method of intrapulmonary administration of a narcotic drug|
|US5915378 *||Oct 27, 1995||Jun 29, 1999||Aradigm Corporation||Creating an aerosolized formulation of insulin|
|US5934272 *||Oct 27, 1995||Aug 10, 1999||Aradigm Corporation||Device and method of creating aerosolized mist of respiratory drug|
|US5938117 *||Apr 5, 1995||Aug 17, 1999||Aerogen, Inc.||Methods and apparatus for dispensing liquids as an atomized spray|
|US5941240 *||Sep 25, 1998||Aug 24, 1999||Aradigm Corporation||Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume|
|US5950619 *||Mar 14, 1996||Sep 14, 1999||Siemens Aktiengesellschaft||Ultrasonic atomizer device with removable precision dosating unit|
|US5957124 *||Sep 27, 1995||Sep 28, 1999||Aradigm Corporation||Dynamic particle size control for aerosolized drug delivery|
|US5960792 *||Oct 27, 1995||Oct 5, 1999||Aradigm Corporation||Device for aerosolized delivery of peptide drugs|
|US5970973 *||Apr 29, 1998||Oct 26, 1999||Aradigm Corporation||Method of delivering insulin lispro|
|US5970974 *||Mar 14, 1996||Oct 26, 1999||Siemens Aktiengesellschaft||Dosating unit for an ultrasonic atomizer device|
|US6012450 *||Jul 1, 1996||Jan 11, 2000||Aradigm Corporation||Intrapulmonary delivery of hematopoietic drug|
|US6014969 *||Oct 26, 1998||Jan 18, 2000||Aradigm Corporation||Disposable package for use in aerosolized delivery of antibiotics|
|US6014970 *||Jun 11, 1998||Jan 18, 2000||Aerogen, Inc.||Methods and apparatus for storing chemical compounds in a portable inhaler|
|US6024090 *||Jun 1, 1998||Feb 15, 2000||Aradigm Corporation||Method of treating a diabetic patient by aerosolized administration of insulin lispro|
|US6085740 *||Apr 10, 1998||Jul 11, 2000||Aerogen, Inc.||Liquid dispensing apparatus and methods|
|US6085753 *||Apr 22, 1998||Jul 11, 2000||Aradigm Corporation||Insulin delivery enhanced by coached breathing|
|US6098615 *||Apr 29, 1998||Aug 8, 2000||Aradigm Corporation||Method of reproducibly effecting a patient's glucose level|
|US6098620 *||Oct 27, 1995||Aug 8, 2000||Aradigm Corporation||Device for aerosolizing narcotics|
|US6116233 *||Feb 28, 1995||Sep 12, 2000||Medic-Aid Limited||Drug delivery arrangement|
|US6123068 *||Apr 24, 1998||Sep 26, 2000||Aradigm Corporation||Systems for the intrapulmonary delivery of aerosolized aqueous formulations|
|US6131567 *||Jan 8, 1998||Oct 17, 2000||Aradigm Corporation||Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin|
|US6138668 *||Nov 26, 1997||Oct 31, 2000||Inhale Therpeutic Systems||Method and device for delivering aerosolized medicaments|
|US6167880||Aug 20, 1999||Jan 2, 2001||Aradigm Corporation||Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume|
|US6192876||Jul 29, 1998||Feb 27, 2001||Astra Aktiebolag||Inhalation apparatus and method|
|US6205999||Sep 8, 1998||Mar 27, 2001||Aerogen, Inc.||Methods and apparatus for storing chemical compounds in a portable inhaler|
|US6235177||Sep 9, 1999||May 22, 2001||Aerogen, Inc.||Method for the construction of an aperture plate for dispensing liquid droplets|
|US6250298||Sep 7, 2000||Jun 26, 2001||Aradigm Corporation||Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin|
|US6260549 *||Jun 18, 1998||Jul 17, 2001||Clavius Devices, Inc.||Breath-activated metered-dose inhaler|
|US6318361 *||Oct 1, 1999||Nov 20, 2001||Clavius Devices Inc.||Breath-activated metered-dose inhaler|
|US6408854||Apr 21, 2000||Jun 25, 2002||Aradigm Corporation||Insulin delivery enhanced by coached breathing|
|US6427681||Jun 21, 2001||Aug 6, 2002||Aradigm Corporation||Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin|
|US6431166||Feb 15, 2001||Aug 13, 2002||Aradigm Corporation||Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin|
|US6431167 *||Oct 9, 2001||Aug 13, 2002||Aradigm Corporation||Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin|
|US6467476||May 18, 2000||Oct 22, 2002||Aerogen, Inc.||Liquid dispensing apparatus and methods|
|US6530370||Sep 16, 1999||Mar 11, 2003||Instrumentation Corp.||Nebulizer apparatus|
|US6539937||Apr 12, 2000||Apr 1, 2003||Instrumentarium Corp.||Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus|
|US6540153||May 27, 1999||Apr 1, 2003||Aerogen, Inc.||Methods and apparatus for dispensing liquids as an atomized spray|
|US6543443||Jul 12, 2000||Apr 8, 2003||Aerogen, Inc.||Methods and devices for nebulizing fluids|
|US6543448||May 30, 2000||Apr 8, 2003||Inhale Therapeutic Systems, Inc.||Apparatus and methods for dispersing dry powder medicaments|
|US6546927||Mar 13, 2001||Apr 15, 2003||Aerogen, Inc.||Methods and apparatus for controlling piezoelectric vibration|
|US6546929||Jun 4, 2001||Apr 15, 2003||Inhale Therapeutic Systems, Inc.||Dry powder dispersing apparatus and methods for their use|
|US6550472||Mar 16, 2001||Apr 22, 2003||Aerogen, Inc.||Devices and methods for nebulizing fluids using flow directors|
|US6554201||May 2, 2001||Apr 29, 2003||Aerogen, Inc.||Insert molded aerosol generator and methods|
|US6598602||Jun 19, 2000||Jul 29, 2003||Siemens-Elema Ab||Medical nebulizer|
|US6606989 *||May 8, 1998||Aug 19, 2003||Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh||Precise administration of a medicated aerosol via the lungs|
|US6629646||Dec 7, 1993||Oct 7, 2003||Aerogen, Inc.||Droplet ejector with oscillating tapered aperture|
|US6640804||Aug 15, 2002||Nov 4, 2003||Aerogen, Inc.||Liquid dispensing apparatus and methods|
|US6647987||Jun 18, 2002||Nov 18, 2003||Aradigm Corporation||Insulin delivery enhanced by coached breathing|
|US6651650 *||Apr 9, 1993||Nov 25, 2003||Omron Corporation||Ultrasonic atomizer, ultrasonic inhaler and method of controlling same|
|US6655376 *||Nov 18, 1999||Dec 2, 2003||Pneumoflex Systems L.L.C.||Aspiration screening process for assessing post surgery patient's risk for pneumonia|
|US6679249 *||Aug 30, 2001||Jan 20, 2004||Pneumoflex Systems, L.L.C.||Apparatus for treatment of chronic obstructive pulmonary disease and associated method|
|US6681767||May 1, 2000||Jan 27, 2004||Nektar Therapeutics||Method and device for delivering aerosolized medicaments|
|US6688304 *||Sep 10, 2001||Feb 10, 2004||Aradigm Corporation||Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume|
|US6729334 *||Mar 10, 1999||May 4, 2004||Trudell Medical Limited||Nebulizing catheter system and methods of use and manufacture|
|US6732944||May 2, 2001||May 11, 2004||Aerogen, Inc.||Base isolated nebulizing device and methods|
|US6755189||May 18, 1999||Jun 29, 2004||Aerogen, Inc.||Methods and apparatus for storing chemical compounds in a portable inhaler|
|US6769626||Oct 30, 2000||Aug 3, 2004||Instrumentarium Corp.||Device and method for detecting and controlling liquid supply to an apparatus discharging liquids|
|US6782886||Mar 20, 2001||Aug 31, 2004||Aerogen, Inc.||Metering pumps for an aerosolizer|
|US6845770||Jan 15, 2003||Jan 25, 2005||Aerogen, Inc.||Systems and methods for clearing aerosols from the effective anatomic dead space|
|US6889690||May 8, 2003||May 10, 2005||Oriel Therapeutics, Inc.||Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages|
|US6901929||Dec 19, 2002||Jun 7, 2005||Nektar Therapeutics||Dry powder dispersing apparatus and methods for their use|
|US6926208||May 2, 2003||Aug 9, 2005||Aerogen, Inc.||Droplet ejector with oscillating tapered aperture|
|US6948491||Mar 20, 2001||Sep 27, 2005||Aerogen, Inc.||Convertible fluid feed system with comformable reservoir and methods|
|US6978779||Apr 19, 2002||Dec 27, 2005||Instrumentarium Corp.||Vibrating element liquid discharging apparatus having gas pressure sensing|
|US6978941||Apr 9, 2004||Dec 27, 2005||Aerogen, Inc.||Base isolated nebulizing device and methods|
|US6985798||Jun 26, 2003||Jan 10, 2006||Oriel Therapeutics, Inc.||Dry powder dose filling systems and related methods|
|US7021309 *||Oct 8, 2003||Apr 4, 2006||Aradigm Corporation||Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin|
|US7028686 *||Nov 4, 2003||Apr 18, 2006||Aradigm Corporation||Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume|
|US7032590||Jan 5, 2004||Apr 25, 2006||Aerogen, Inc.||Fluid filled ampoules and methods for their use in aerosolizers|
|US7040549||Mar 21, 2003||May 9, 2006||Aerogen, Inc.||Systems and methods for controlling fluid feed to an aerosol generator|
|US7066398||Mar 30, 2001||Jun 27, 2006||Aerogen, Inc.||Aperture plate and methods for its construction and use|
|US7083112||Jun 6, 2005||Aug 1, 2006||Aerogen, Inc.||Method and apparatus for dispensing liquids as an atomized spray|
|US7100600||Mar 20, 2001||Sep 5, 2006||Aerogen, Inc.||Fluid filled ampoules and methods for their use in aerosolizers|
|US7104463||Oct 6, 2005||Sep 12, 2006||Aerogen, Inc.||Base isolated nebulizing device and methods|
|US7108197 *||May 9, 2005||Sep 19, 2006||Aerogen, Inc.||Droplet ejector with oscillating tapered aperture|
|US7118010||Jun 26, 2003||Oct 10, 2006||Oriel Therapeutics, Inc.||Apparatus, systems and related methods for dispensing and /or evaluating dry powders|
|US7174888||Sep 5, 2003||Feb 13, 2007||Aerogen, Inc.||Liquid dispensing apparatus and methods|
|US7195011||Jun 30, 2004||Mar 27, 2007||Aerogen, Inc.||Convertible fluid feed system with comformable reservoir and methods|
|US7201163 *||Jan 7, 2003||Apr 10, 2007||The Brigham And Women's Hospital, Inc.||Method for altering the body temperature of a patient using a nebulized mist|
|US7201167 *||Mar 14, 2005||Apr 10, 2007||Aerogen, Inc.||Method and composition for the treatment of lung surfactant deficiency or dysfunction|
|US7267121 *||Sep 30, 2004||Sep 11, 2007||Aerogen, Inc.||Aerosol delivery apparatus and method for pressure-assisted breathing systems|
|US7290541 *||Jun 30, 2004||Nov 6, 2007||Aerogen, Inc.||Aerosol delivery apparatus and method for pressure-assisted breathing systems|
|US7306787||Mar 12, 2002||Dec 11, 2007||Nektar Therapeutics||Engineered particles and methods of use|
|US7322349 *||Jun 18, 2003||Jan 29, 2008||Aerogen, Inc.||Apparatus and methods for the delivery of medicaments to the respiratory system|
|US7331339||Nov 23, 2004||Feb 19, 2008||Aerogen, Inc.||Methods and systems for operating an aerosol generator|
|US7360536||Jan 7, 2003||Apr 22, 2008||Aerogen, Inc.||Devices and methods for nebulizing fluids for inhalation|
|US7377277||Oct 21, 2004||May 27, 2008||Oriel Therapeutics, Inc.||Blister packages with frames and associated methods of fabricating dry powder drug containment systems|
|US7422013||Mar 9, 2005||Sep 9, 2008||Nektar Therapeutics||Dry powder dispersing apparatus and methods for their use|
|US7428446||Jul 12, 2005||Sep 23, 2008||Oriel Therapeutics, Inc.||Dry powder dose filling systems and related methods|
|US7448375||May 17, 2005||Nov 11, 2008||Aradigm Corporation||Method of treating diabetes mellitus in a patient|
|US7451761||Oct 21, 2004||Nov 18, 2008||Oriel Therapeutics, Inc.||Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances|
|US7458372||Oct 30, 2003||Dec 2, 2008||Pari Pharma Gmbh||Inhalation therapy device|
|US7469700||Jun 25, 2003||Dec 30, 2008||Trudell Medical Limited||Nebulizing catheter system for delivering an aerosol to a patient|
|US7472705||Jun 25, 2003||Jan 6, 2009||Trudell Medical Limited||Methods of forming a nebulizing catheter|
|US7490603 *||Nov 21, 2005||Feb 17, 2009||Aradigm Corporation||Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin|
|US7520278||Jan 26, 2005||Apr 21, 2009||Oriel Therapeutics, Inc.||Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages|
|US7600511||Oct 30, 2002||Oct 13, 2009||Novartis Pharma Ag||Apparatus and methods for delivery of medicament to a respiratory system|
|US7622510 *||Oct 15, 2003||Nov 24, 2009||Christophe Arnaud||Method and device for making a dispersion or an emulsion|
|US7628339||May 5, 2006||Dec 8, 2009||Novartis Pharma Ag||Systems and methods for controlling fluid feed to an aerosol generator|
|US7628978||Aug 19, 2003||Dec 8, 2009||Novartis Pharma Ag||Stabilized preparations for use in metered dose inhalers|
|US7677411||Jun 27, 2003||Mar 16, 2010||Oriel Therapeutics, Inc.||Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders|
|US7677467 *||Apr 20, 2005||Mar 16, 2010||Novartis Pharma Ag||Methods and devices for aerosolizing medicament|
|US7712680 *||Jan 30, 2006||May 11, 2010||Sono-Tek Corporation||Ultrasonic atomizing nozzle and method|
|US7748377||Oct 30, 2007||Jul 6, 2010||Novartis Ag||Methods and systems for operating an aerosol generator|
|US7771642||Apr 1, 2005||Aug 10, 2010||Novartis Ag||Methods of making an apparatus for providing aerosol for medical treatment|
|US7871598||May 10, 2000||Jan 18, 2011||Novartis Ag||Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use|
|US7883031||May 20, 2004||Feb 8, 2011||James F. Collins, Jr.||Ophthalmic drug delivery system|
|US7914517||Nov 1, 2004||Mar 29, 2011||Trudell Medical International||System and method for manipulating a catheter for delivering a substance to a body cavity|
|US7931212||Jul 31, 2003||Apr 26, 2011||Pari Pharma Gmbh||Fluid droplet production apparatus and method|
|US7946291 *||Apr 20, 2004||May 24, 2011||Novartis Ag||Ventilation systems and methods employing aerosol generators|
|US7958887||Mar 8, 2007||Jun 14, 2011||Aradigm Corporation||Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations|
|US7971588||Mar 24, 2005||Jul 5, 2011||Novartis Ag||Methods and systems for operating an aerosol generator|
|US8012136||Jan 26, 2007||Sep 6, 2011||Optimyst Systems, Inc.||Ophthalmic fluid delivery device and method of operation|
|US8161969||Mar 21, 2008||Apr 24, 2012||Novartis Ag||Dry powder dispersing apparatus and methods for their use|
|US8168223||Jun 21, 2001||May 1, 2012||Novartis Pharma Ag||Engineered particles and methods of use|
|US8196573||Jan 23, 2008||Jun 12, 2012||Novartis Ag||Methods and systems for operating an aerosol generator|
|US8201554||Mar 13, 2009||Jun 19, 2012||Injet Digital Aerosols Limited||Inhalation device having an optimized air flow path|
|US8246934||Sep 3, 2010||Aug 21, 2012||Novartis Ag||Respiratory dispersion for metered dose inhalers comprising perforated microstructures|
|US8332020||Jan 28, 2011||Dec 11, 2012||Proteus Digital Health, Inc.||Two-wrist data gathering system|
|US8336545||Jan 16, 2007||Dec 25, 2012||Novartis Pharma Ag||Methods and systems for operating an aerosol generator|
|US8348177||Jun 15, 2009||Jan 8, 2013||Davicon Corporation||Liquid dispensing apparatus using a passive liquid metering method|
|US8349294||Dec 14, 2010||Jan 8, 2013||Novartis Ag||Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use|
|US8371290||Oct 9, 2008||Feb 12, 2013||General Electric Company||Device for delivery and regulation of volatile fluids into inspiratory gas|
|US8371299||Apr 10, 2008||Feb 12, 2013||Respironics Respiratory Drug Delivery||Ventilator aerosol delivery|
|US8398001||Jun 19, 2006||Mar 19, 2013||Novartis Ag||Aperture plate and methods for its construction and use|
|US8404217||Jul 22, 2005||Mar 26, 2013||Novartis Ag||Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use|
|US8419638||Nov 18, 2008||Apr 16, 2013||Proteus Digital Health, Inc.||Body-associated fluid transport structure evaluation devices|
|US8511581||Mar 8, 2011||Aug 20, 2013||Pari Pharma Gmbh||Fluid droplet production apparatus and method|
|US8539944||Apr 8, 2008||Sep 24, 2013||Novartis Ag||Devices and methods for nebulizing fluids for inhalation|
|US8545463||Jan 26, 2007||Oct 1, 2013||Optimyst Systems Inc.||Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device|
|US8561604||Feb 12, 2007||Oct 22, 2013||Novartis Ag||Liquid dispensing apparatus and methods|
|US8578931||Apr 18, 2000||Nov 12, 2013||Novartis Ag||Methods and apparatus for storing chemical compounds in a portable inhaler|
|US8616195||Apr 27, 2004||Dec 31, 2013||Novartis Ag||Nebuliser for the production of aerosolized medication|
|US8684980||Jul 15, 2011||Apr 1, 2014||Corinthian Ophthalmic, Inc.||Drop generating device|
|US8709484||Oct 24, 2008||Apr 29, 2014||Novartis Ag||Phospholipid-based powders for drug delivery|
|US8715623||Oct 31, 2007||May 6, 2014||Novartis Ag||Pulmonary delivery of aminoglycoside|
|US8733343 *||Oct 29, 2007||May 27, 2014||Universidad De Sevilla||Device and method for creating aerosols for drug delivery|
|US8733935||Jul 15, 2011||May 27, 2014||Corinthian Ophthalmic, Inc.||Method and system for performing remote treatment and monitoring|
|US8877162||Dec 6, 2012||Nov 4, 2014||Novartis Ag||Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery|
|US8936021||Oct 6, 2008||Jan 20, 2015||Optimyst Systems, Inc.||Ophthalmic fluid delivery system|
|US9008761||Nov 6, 2012||Apr 14, 2015||Proteus Digital Health, Inc.||Two-wrist data gathering system|
|US9014779||Jan 28, 2011||Apr 21, 2015||Proteus Digital Health, Inc.||Data gathering system|
|US9022027 *||May 2, 2013||May 5, 2015||Pneumoflex Systems, Llc||Nebulizer with intra-oral vibrating mesh|
|US9027548 *||Jan 17, 2006||May 12, 2015||Pari Pharma Gmbh||Aerosol generating device and inhalation therapy unit provided with this device|
|US9084566||Jan 6, 2009||Jul 21, 2015||Proteus Digital Health, Inc.||Smart parenteral administration system|
|US9087145||Jul 15, 2011||Jul 21, 2015||Eyenovia, Inc.||Ophthalmic drug delivery|
|US9108211||Apr 17, 2006||Aug 18, 2015||Nektar Therapeutics||Vibration systems and methods|
|US9125979||Oct 24, 2008||Sep 8, 2015||Proteus Digital Health, Inc.||Fluid transfer port information system|
|US9227029 *||Oct 2, 2013||Jan 5, 2016||Pneumoflex Systems, Llc||Nebulizer having horizontal venturi|
|US9421166||Apr 8, 2014||Aug 23, 2016||Novartis Ag||Pulmonary delivery of aminoglycoside|
|US9439862||Apr 2, 2014||Sep 13, 2016||Novartis Ag||Phospholipid-based powders for drug delivery|
|US9532597||Feb 22, 2013||Jan 3, 2017||Altria Client Services Llc||Electronic smoking article|
|US9554993||May 5, 2010||Jan 31, 2017||Novartis Ag||Pulmonary delivery particles comprising an active agent|
|US9565870 *||Oct 31, 2012||Feb 14, 2017||Pepsico, Inc.||Dispensing nozzle with an ultrasound activator|
|US20030072717 *||Feb 22, 2002||Apr 17, 2003||Vapotronics, Inc.||Inhalation device having an optimized air flow path|
|US20030136402 *||Jan 7, 2003||Jul 24, 2003||Brigham And Women's Hospital, Inc.||Method for altering the body temperature of a patient using a nebulized mist|
|US20030209243 *||Dec 19, 2002||Nov 13, 2003||Inhale Therapeutic Systems||Dry powder dispersing apparatus and methods for their use|
|US20030226906 *||May 2, 2003||Dec 11, 2003||Aerogen, Inc.||Droplet ejector with oscillating tapered aperture|
|US20040039755 *||Jun 5, 2003||Feb 26, 2004||Matthew Kunze||Metadata relationships|
|US20040050860 *||Jun 26, 2003||Mar 18, 2004||Crowder Timothy M.||Apparatus, systems and related methods for dispensing and /or evaluating dry powders|
|US20040055598 *||Jun 27, 2003||Mar 25, 2004||Crowder Timothy M.||Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders|
|US20040062722 *||Oct 8, 2003||Apr 1, 2004||Igor Gonda||Method of use of monomeric insulin as a means for improving the reproducibilty of inhaled insulin|
|US20040089290 *||Nov 4, 2003||May 13, 2004||Aradigm Corporation||Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume|
|US20040139968 *||Jan 5, 2004||Jul 22, 2004||Aerogen, Inc.||Fluid filled ampoules and methods for their use in aerosolizers|
|US20040153262 *||Jun 26, 2003||Aug 5, 2004||Crowder Timothy M.||Dry powder dose filling systems and related methods|
|US20040170568 *||Aug 19, 2003||Sep 2, 2004||Weers Jeffry G.||Stabilized preparations for use in metered dose inhalers|
|US20040256487 *||May 20, 2004||Dec 23, 2004||Collins James F.||Ophthalmic drug delivery system|
|US20050034719 *||Oct 16, 2002||Feb 17, 2005||Franz Feiner||Inhalation therapy apparatus|
|US20050042170 *||Feb 12, 2004||Feb 24, 2005||The Brigham And Women's Hospital, Inc.||Method and device for generating mists and medical uses thereof|
|US20050103337 *||Oct 21, 2004||May 19, 2005||Anthony James Hickey||Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances|
|US20050109659 *||Oct 21, 2004||May 26, 2005||Hickey Anthony J.||Blister packages with frames and associated methods of fabricating dry powder drug containment systems|
|US20050125002 *||Nov 1, 2004||Jun 9, 2005||George Baran||System and method for manipulating a catheter for delivering a substance to a body cavity|
|US20050126569 *||Jan 26, 2005||Jun 16, 2005||Crowder Timothy M.||Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages|
|US20050133024 *||Nov 24, 2004||Jun 23, 2005||Coifman Robert E.||Devices for measuring inspiratory airflow|
|US20050229927 *||Apr 20, 2004||Oct 20, 2005||Aerogen, Inc.||Ventilation systems and methods employing aerosol generators|
|US20050263608 *||May 9, 2005||Dec 1, 2005||Aerogen, Inc.||Droplet ejector with oscillating tapered aperture|
|US20050267628 *||Jul 12, 2005||Dec 1, 2005||Oriel Therapeutics, Inc.||Dry powder dose filling systems and related methods|
|US20050274377 *||May 17, 2005||Dec 15, 2005||Igor Gonda||Method of treating diabetes mellitus in a patient|
|US20050279349 *||Oct 24, 2003||Dec 22, 2005||Patton John S||Method and device for delivering aerosolized medicaments|
|US20050279851 *||Jun 6, 2005||Dec 22, 2005||Aerogen, Inc.||Method and apparatus for dispensing liquids as an atomized spray|
|US20060001952 *||Jul 7, 2004||Jan 5, 2006||Liekki Oy||Method and device for producing optical material, and an optical waveguide|
|US20060093556 *||Nov 21, 2005||May 4, 2006||Aradigm Corporation||Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin|
|US20060097068 *||Jul 31, 2003||May 11, 2006||Markus Urich||Fluid droplet production apparatus and method|
|US20060102172 *||Oct 30, 2003||May 18, 2006||Pari Gmbh Spezialisten Fur Effektive Inhalation||Inhalation therapy device|
|US20060124125 *||Jan 31, 2006||Jun 15, 2006||Igor Gonda||Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume|
|US20060164912 *||Oct 15, 2003||Jul 27, 2006||Christophe Arnaud||Method and device for making a dispersion or an emulsion|
|US20060237090 *||Mar 11, 2004||Oct 26, 2006||Prolitec, S.A.||Method and device for nebulisation|
|US20070023547 *||Jun 19, 2006||Feb 1, 2007||Aerogen, Inc.||Aperture plate and methods for its construction and use|
|US20070075161 *||Sep 18, 2006||Apr 5, 2007||Aerogen, Inc.||Droplet Ejector With Oscillating Tapered Aperture|
|US20070102533 *||Dec 22, 2006||May 10, 2007||Aradigm Corporation; Universidad De Sevilla||Aerosol created by directed flow of fluids and devices and methods for producing same|
|US20070176017 *||Jan 30, 2006||Aug 2, 2007||Berger Harvey L||Ultrasonic atomizing nozzle and method|
|US20070209659 *||Feb 12, 2007||Sep 13, 2007||Aerogen, Inc.||Liquid dispensing apparatus and methods|
|US20070256684 *||Mar 8, 2007||Nov 8, 2007||Aradigm Corporation||Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations|
|US20080053431 *||Oct 29, 2007||Mar 6, 2008||The Universidad De Sevilla||Device and method for creating aerosols for drug delivery|
|US20080053436 *||Oct 30, 2007||Mar 6, 2008||Aradigm Corporation||Aerosol created by directed flow of fluids and devices and methods for producing same|
|US20080099010 *||Oct 25, 2007||May 1, 2008||Igor Gonda||Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin|
|US20080099011 *||Oct 26, 2007||May 1, 2008||Novo Nordisk||Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume|
|US20080197044 *||Apr 25, 2008||Aug 21, 2008||Oriel Therapeutics, Inc.||Blister packages with frames for dry powder drug containment|
|US20080230058 *||Mar 21, 2008||Sep 25, 2008||Nektar Therapeutics||Dry powder dispersing apparatus and methods for their use|
|US20080257337 *||Apr 10, 2008||Oct 23, 2008||Denyer Jonathan S H||Ventilator Aerosol Delivery|
|US20080264416 *||Jul 2, 2008||Oct 30, 2008||Novo Nordisk A/S||Method of Treating Diabetes Mellitus in a Patient|
|US20080308096 *||Jan 17, 2006||Dec 18, 2008||Pari Pharma Gmbh||Aerosol Generating Device and Inhalation Therapy Unit Provided with This Device|
|US20090022669 *||Jun 20, 2008||Jan 22, 2009||Vapotronics, Inc.||Compositions for protein delivery via the pulmonary route|
|US20090107503 *||Oct 22, 2008||Apr 30, 2009||Trudell Medical Limited||Nebulizing catheter system and methods of use and manufacture|
|US20090173341 *||Mar 13, 2009||Jul 9, 2009||Injet Digital Aerosols Limited||Inhalation device having an optimized air flow path|
|US20090241950 *||May 12, 2009||Oct 1, 2009||Aradigm Corporation||Method of treating diabetes mellitus in a patient|
|US20090288659 *||May 13, 2009||Nov 26, 2009||Heikki Haveri||Apparatus, system and method for administering an anesthetic agent for a subject breathing|
|US20090308945 *||Jun 15, 2009||Dec 17, 2009||Jacob Loverich||Liquid dispensing apparatus using a passive liquid metering method|
|US20110155768 *||Mar 8, 2011||Jun 30, 2011||Pari Pharma Gmbh||Fluid droplet production apparatus and method|
|US20120318259 *||Jan 12, 2011||Dec 20, 2012||Omega Life Science Ltd.||Method and apparatus for producing fine concentrated aerosol|
|US20130108748 *||Oct 31, 2012||May 2, 2013||Pepsico., Inc.||Dispensing Nozzle with an Ultrasound Activator|
|US20130267864 *||May 2, 2013||Oct 10, 2013||Pneumoflex Systems, Llc||Nebulizer with intra-oral vibrating mesh|
|US20140034051 *||Oct 2, 2013||Feb 6, 2014||Pneumoflex Systems, Llc||Nebulizer having horizontal venturi|
|US20140053835 *||Feb 15, 2013||Feb 27, 2014||Capnia, Inc.||Gas dispenser with diffusing nosepiece|
|US20140110500 *||May 16, 2012||Apr 24, 2014||The Technology Partnership Plc.||Separable membrane improvements|
|DE4300880A1 *||Jan 15, 1993||Jul 21, 1994||Draegerwerk Ag||Ultraschallvernebler mit Dosiereinheit|
|EP0156409A2 *||Feb 18, 1985||Oct 2, 1985||Jean Michel Anthony||Device for moistening parts of the human body|
|EP0156409A3 *||Feb 18, 1985||Jun 25, 1986||Jean Michel Anthony||Device for moistening parts of the human body|
|EP0186280A2 *||Oct 25, 1985||Jul 2, 1986||Robert Landis||Breath activated medication spray|
|EP0186280A3 *||Oct 25, 1985||Jan 13, 1988||Robert Landis||Breath activated medication spray|
|EP0200258A2 *||Apr 17, 1986||Nov 5, 1986||Jean Michel Anthony||Ultrasonic spraying device|
|EP0200258A3 *||Apr 17, 1986||Feb 3, 1988||Jean Michel Anthony||Ultrasonic spraying device|
|EP0232235A2 *||Jan 23, 1987||Aug 12, 1987||A/S GEA Farmaceutisk Fabrik||Medical dosing device for discharge of atomized medicament for inhalation air|
|EP0642802A2 *||Aug 5, 1994||Mar 15, 1995||Disetronic Ag||Inhalation device|
|EP0642802A3 *||Aug 5, 1994||Mar 13, 1996||Disetronic Ag||Inhalation device.|
|EP0844027A1 *||Aug 5, 1996||May 27, 1998||Omron Corporation||Atomization apparatus and method utilizing surface acoustic waves|
|EP0844027A4 *||Aug 5, 1996||Jun 13, 2001||Omron Tateisi Electronics Co||Atomization apparatus and method utilizing surface acoustic waves|
|EP1066850A1 *||Apr 28, 2000||Jan 10, 2001||Siemens Elema AB||Medical Nebulizer|
|EP1219313A1||Dec 29, 2000||Jul 3, 2002||Instrumentarium Corporation||Liquid discharging apparatus and magneto-shape-memory type valve|
|EP1219314A1||Dec 29, 2000||Jul 3, 2002||Instrumentarium Corporation||Liquid discharge apparatus having magnetic valve|
|EP1227856A1 *||Oct 27, 2000||Aug 7, 2002||PARI GmbH Spezialisten für effektive Inhalation||Inhalation nebulizer|
|EP1227856A4 *||Oct 27, 2000||Jan 3, 2007||Pari Gmbh||Inhalation nebulizer|
|EP1310268A3 *||Jul 10, 1995||Nov 26, 2003||Aradigm Corporation||Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values|
|EP1694392A2 *||Nov 24, 2004||Aug 30, 2006||Robert E. Coifman||Devices for measuring inspiratory airflow|
|EP1694392A4 *||Nov 24, 2004||May 14, 2008||Robert E Coifman||Devices for measuring inspiratory airflow|
|EP2050478A1 *||Oct 16, 2007||Apr 22, 2009||GE Healthcare Finland Oy||Device for delivery and regulation of volatile fluids into inspiratory gas|
|EP2050479A2 *||May 20, 2008||Apr 22, 2009||General Electric Company||Apparatus, system and method for admistering an anesthetic agent for a subject breathing|
|EP2050479A3 *||May 20, 2008||Jun 19, 2013||General Electric Company||Apparatus, system and method for admistering an anesthetic agent for a subject breathing|
|EP2119465A1 *||May 16, 2008||Nov 18, 2009||Markos Mefar S.P.A.||Nebulizer with breathing phase detecting sensor for delivering nebulized drugs to a user|
|WO1989006147A1 *||Oct 27, 1988||Jul 13, 1989||Etelä-Hämeen Keuhkovammayhdistys R.Y.||Ultrasonic atomizer|
|WO1992011050A1 *||Dec 17, 1991||Jul 9, 1992||Minnesota Mining And Manufacturing Company||Inhaler|
|WO1992011512A1 *||Dec 17, 1991||Jul 9, 1992||Minnesota Mining And Manufacturing Company||Device for measuring a pre-determined volume of liquid flowing there through|
|WO1996001663A1 *||Jul 10, 1995||Jan 25, 1996||Aradigm Corporation||Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values|
|WO1996013290A1 *||Oct 27, 1995||May 9, 1996||Aradigm Corporation||Device for aerosolized delivery of peptide drugs|
|WO1996013291A1 *||Oct 27, 1995||May 9, 1996||Aradigm Corporation||Device for aerosolizing narcotics|
|WO1996013292A1 *||Oct 27, 1995||May 9, 1996||Aradigm Corporation||Device and method of creating aerosolized mist of respiratory drug|
|WO1996028205A1 *||Mar 14, 1996||Sep 19, 1996||Siemens Aktiengesellschaft||Ultrasonic atomizer device with removable precision dosing unit|
|WO1996028206A1 *||Mar 14, 1996||Sep 19, 1996||Siemens Aktiengesellschaft||Ultrasonic atomizer device with removable precision dosating unit|
|WO1996030068A1 *||Mar 15, 1996||Oct 3, 1996||Aradigm Corporation||Intrapulmonary delivery of hematopoietic drug|
|WO1996031289A1||Apr 3, 1996||Oct 10, 1996||Fluid Propulsion Technologies, Inc.||Methods and apparatus for dispensing liquids as an atomized spray|
|WO1997018846A1 *||Nov 18, 1996||May 29, 1997||R + D Injector Ag||Nebulizing device|
|WO1997031721A1 *||Feb 27, 1997||Sep 4, 1997||Medix Limited||A nebuliser|
|WO2001019437A1||Sep 8, 2000||Mar 22, 2001||Instrumentarium Corporation||Nebulizer apparatus|
|WO2001032246A1 *||Nov 3, 2000||May 10, 2001||Pari GmbH Spezialisten für effektive Inhalation||Inhalation nebuliser|
|WO2001076762A2||Apr 4, 2001||Oct 18, 2001||Instrumentarium Corporation||Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus|
|WO2002036269A1||Oct 12, 2001||May 10, 2002||Instrumentarium Corporation||Device and method for detecting and controlling liquid supply to an apparatus discharging liquid|
|WO2002087772A1 *||May 1, 2002||Nov 7, 2002||Aerogen, Inc.||Cymbal-shaped actuator for a nebulizing element|
|WO2003059423A1 *||Jan 15, 2003||Jul 24, 2003||Aerogen, Inc.||Systems and methods for clearing aerosols from the effective anatomic dead space|
|WO2005011574A2 *||Jul 23, 2004||Feb 10, 2005||Coifman Robert E||Microporous membrane nebulizers|
|WO2005011574A3 *||Jul 23, 2004||Oct 20, 2005||Robert E Coifman||Microporous membrane nebulizers|
|WO2005051177A3 *||Nov 24, 2004||Mar 16, 2006||Robert E Coifman||Devices for measuring inspiratory airflow|
|WO2005102431A3 *||Apr 20, 2005||Jun 22, 2006||Aerogen Inc||Aerosol delivery apparatus for pressure assisted breathing|
|WO2007106386A2||Mar 9, 2007||Sep 20, 2007||Aradgim Corporation||Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations|
|WO2010107952A2||Mar 17, 2010||Sep 23, 2010||Merck Sharp & Dohme Corp.||RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)|
|WO2010107955A2||Mar 17, 2010||Sep 23, 2010||Merck Sharp & Dohme Corp.||RNA INTERFERENCE MEDIATED INHIBITION OF BTB AND CNC HOMOLOGY 1, BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR 1 (BACH 1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) SEQUENCE LISTING|
|WO2010107957A2||Mar 17, 2010||Sep 23, 2010||Merck Sharp & Dohme Corp.||RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)|
|WO2010107958A1||Mar 17, 2010||Sep 23, 2010||Merck Sharp & Dohme Corp.||RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)|
|WO2010111464A1||Mar 25, 2010||Sep 30, 2010||Merck Sharp & Dohme Corp.||RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)|
|WO2010111468A2||Mar 25, 2010||Sep 30, 2010||Merck Sharp & Dohme Corp.||RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)|
|WO2010111471A2||Mar 25, 2010||Sep 30, 2010||Merck Sharp & Dohme Corp.||RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)|
|WO2010111490A2||Mar 25, 2010||Sep 30, 2010||Merck Sharp & Dohme Corp.||RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)|
|WO2010111497A2||Mar 25, 2010||Sep 30, 2010||Merck Sharp & Dohme Corp.||RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)|
|WO2012156724A2||May 16, 2012||Nov 22, 2012||The Technology Partnership Plc||Separable membrane improvements|
|WO2017006091A1||Jul 1, 2016||Jan 12, 2017||The Technology Partnership Plc||Aerosol apparatus with improved separable membrane|
|U.S. Classification||128/200.16, 239/102.2|
|International Classification||B05B17/06, A61M15/00, A61M11/00|
|Cooperative Classification||B05B17/063, B05B17/0623, A61M15/0085, A61M2011/001|
|European Classification||B05B17/06B2B, A61M15/00F, B05B17/06B2|